Identification of platelet-related subtypes and diagnostic markers in pediatric Crohn's disease based on WGCNA and

Dadong Tang1, Yingtao Huang2, Yuhui Che1

  • 1Clinical Medical College, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

Frontiers in Immunology
|February 29, 2024
PubMed

Insights

Researchers identified five key diagnostic markers for pediatric Crohn's disease (PCD), a condition with increasing incidence. These markers aid in developing predictive models and understanding distinct PCD subtypes for improved early diagnosis and personalized treatment strategies.

Area of Science:

  • Genomics and Bioinformatics
  • Immunology
  • Pediatric Gastroenterology

Background:

  • Pediatric Crohn's disease (PCD) incidence is rising globally.
  • Early diagnosis and treatment are challenging due to PCD's heterogeneity.
  • There is a need for novel diagnostic markers and molecular subtypes to improve PCD prognosis.

Purpose of the Study:

  • To identify novel diagnostic markers for PCD.
  • To discover molecular subtypes of PCD.
  • To enhance diagnostic and prognostic capabilities for PCD patients.

Main Methods:

  • Weighted gene co-expression network analysis (WGCNA) and differential analysis were used to identify candidate genes.
  • Five machine learning algorithms screened for pivotal diagnostic markers.
  • Consensus clustering identified PCD subtypes, followed by pathway and immune infiltration analysis.

Main Results:

  • Five key diagnostic markers (GNA15, PIK3R3, PLEK, SERPINE1, STAT1) were identified.
  • A high-performing nomogram was developed based on these markers.
  • Two distinct platelet-related PCD subtypes with differential gene expression and immune infiltration were discovered.

Conclusions:

  • Five promising diagnostic markers and a predictive nomogram for PCD were successfully developed.
  • The identification of distinct PCD subtypes deepens the understanding of pathogenic mechanisms.
  • These findings offer potential for improved early diagnosis and personalized treatment of PCD.
Abstract